HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Cytotoxic activity of Macrosolen parasiticus (L.) Danser on the growth of breast cancer cell line (MCF-7).

AbstractBACKGROUND:
Macrosolen parasiticus (L.) Danser belonging to Loranthaceaea (mistletoe family) is a parasitic plant that grows on different host plants such as mango, jack fruit, peepal, neem tree, etc., This study was aimed to investigate the anti-cancer activity of methanolic and aqueous extract of stem of M. parasiticus.
OBJECTIVES:
To investigate the in vitro cytotoxic potential of the methanolic and aqueous extracts from stems of M. parasiticus against MCF-7 breast cancer cells by brine shrimp lethality (BSL) bioassay, MTT assay and sulforhodamine B (SRB) assay.
MATERIALS AND METHODS:
The extracts were tested in human breast cancer cell lines in vitro for percentage cytotoxicity, apoptosis by acridine orange/ethidium bromide staining, LD50 and IC50 values after treatment with M. parasiticus extracts.
RESULTS:
In BSL bioassay, aqueous extract showed more significant (P < 0.01) cytotoxicity with LD50 82.79 ± 2.67 μg/mL as compared to methanolic extract with LD50 125 ± 3.04 μg/mL. The methanolic extract of M. parasiticus showed IC50 97.33 ± 3.75 μg/mL (MTT) (P < 0.05) and 94.58 ± 3.84 μg/mL (SRB) (P < 0.01) assays against MCF-7. The aqueous extract of M. parasiticus demonstrated higher activity with IC50 59.33 ± 3.3 μg/mL (MTT) (P < 0.01) and 51.9 ± 1.87 μg/mL (SRB)(P < 0.01) assays, after 48 h of exposure and thus showed significant dose-dependent cytotoxic activity.
CONCLUSION:
The finding demonstrated that both extracts of M. parasiticus showed significant cytotoxic activity, however aqueous extract demonstrated higher activity against MCF-7 breast cancer cells.
AuthorsVijay Kumar Sodde, Richard Lobo, Nimmy Kumar, Rajalekshmi Maheshwari, C S Shreedhara
JournalPharmacognosy magazine (Pharmacogn Mag) Vol. 11 Issue Suppl 1 Pg. S156-60 (May 2015) ISSN: 0973-1296 [Print] India
PMID26109761 (Publication Type: Journal Article)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: